Page last updated: 2024-08-26

yttrium radioisotopes and Neoplasms

yttrium radioisotopes has been researched along with Neoplasms in 133 studies

Research

Studies (133)

Timeframe	Studies, this research(%)	All Research%
pre-1990	28 (21.05)	18.7374
1990's	23 (17.29)	18.2507
2000's	44 (33.08)	29.6817
2010's	32 (24.06)	24.3611
2020's	6 (4.51)	2.80

Authors

Authors	Studies
Abdelsalam, ME; Agahi, KN; Mahvash, A	1
Giesel, FL; Haberkorn, U; Kratochwil, C; Mori, Y	1
Helmberger, T	1
Agopian, VG; DiNorcia, J; Johnson, GE; Padia, SA; Sayre, J; Shin, DS; Srinivasa, RN	1
Fisher, DR	1
Bednarz, B; Lee, D; Li, M; Schultz, MK	1
d'Abadie, P; Hesse, M; Jamar, F; Lhommel, R; Louppe, A; Walrand, S	1
Pooley, RA; Sturchio, GM	1
Bishay, V; Fischman, AM; Kim, E; Lekperic, S; Loewenstern, J; Lookstein, RA; Nowakowski, FS; Patel, RS; Ranade, M; Welch, C	1
Cox, MG; Flux, GD; Gear, JI; Glatting, G; Gleisner, KS; Gustafsson, J; Konijnenberg, M; Murray, I	1
Gandhi, RT	1
Assi, PE; Bordim, A; da Fonseca, LM; Gabriel, MB; Gutfilen, B; Lorenzato, CS; Mendes, JD; Pacheco, LR; Souza, SA; Thomas, S	1
Hadadi, A; Khanchi, A; Sadeghi, M; Sardari, D; Shirazi, A	1
Astsaturov, I; Ball, DS; Cade, DN; Cohen, SJ; Dickens, A; Konski, AA; Marlow, C; Meropol, NJ; Meyer, JE; Putnam, S; Yu, JQ	1
Bauer, N; Hausner, SH; Satpati, D; Sutcliffe, JL	1
Celler, A; Grimes, J	1
Kawashima, H	1
Környei, J; Mikecz, P; Tóth, G	1
Barsegian, V; Bockisch, A; Horn, PA; Hueben, C; Lindemann, M; Mueller, SP; Poeppel, TD	1
Chaal, J; Conti, M; Soderlund, AT; Tjio, G; Totman, JJ; Townsend, DW	1
Feron, O; Gallez, B; Lucas, S; Masereel, B; Michiels, C; Vander Borght, T	1
Agrawal, A; Jha, AK; Kulkarni, SS; Purandare, N; Rangarajan, V; Shah, SA	1
Galt, JR; Halkar, R; Kendi, AT; Moncayo, VM; Nye, JA; Schuster, DM	1
DeNardo, GL; Meredith, RF; Williams, LE	1
Dubel, GJ; Soares, GM	1
Baechler, S; Bischof-Delaloye, A; Hobbs, RF; Prideaux, AR; Recordon, M; Sgouros, G	1
Bombardieri, E; Canevari, S; Coliva, A; Figini, M; Giussani, A; Luison, E; Seregni, E; Zacchetti, A	1
Gopal, AK; Winter, JN	1
Baidoo, KE; Brechbiel, MW; Garmestani, K; Milenic, DE; Nayak, TK; Regino, CA; Szajek, LP; Wong, KJ	1
Baidoo, KE; Brechbiel, MW; Garmestani, K; Milenic, DE; Nayak, TK	1
Chen, X; Jia, B; Li, F; Liu, S; Liu, Y; Liu, Z; Shi, J; Tian, J; Wang, F; Yu, Z; Zhao, H	1
Gadaleta, CD; Goffredo, V; Paradiso, A; Ranieri, G	1
de Jong, M; Konijnenberg, MW	1
Antunovic, L; Bombardieri, E; Castellani, MR; Chiti, A; Fanti, S; Lopci, E; Pepe, G	1
Daghir, AA; Gungor, H; Haydar, AA; Tait, NP; Wasan, HS	1
Brechbiel, MW; Nayak, TK	1
Ahmadzadehfar, H; Biermann, K; Biersack, HJ; Ezziddin, S; Haslerud, T; Kuhl, C; Muckle, M; Sabet, A; Wilhelm, K	1
Cui, L; Huang, J; Liu, Z; Wang, F	1
Chiacchiararelli, L; Cicone, F; Coniglio, A; D'Arienzo, M; Delaloye, AB; Scopinaro, F	1
Dreher, MR; Frenkel, V; Hancock, H; Jang, BS; Kim, HS; Lee, SM; Paik, CH; Pastan, I; Shin, IS; Wang, S; Zderic, V	1
Alberini, JL; Bellet, D; Pecking, AP	1
Gabriel, M	1
Hanna, M; Mikko, T	1
Crowe, EA; Siegel, JA; Sparks, RB; Toohey, RE; Wong, FC	1
Andreae, F; Angelberger, P; Burggasser, G; Dudczak, R; Füger, B; Kurtaran, A; Leimer, M; Li, SR; Novotny, C; Pangerl, T; Patri, P; Raderer, M; Traub, T; Virgolini, I	1
Podoloff, DA	1
Bartolomei, M; Bodei, L; Caracciolo, M; Chinol, M; Cremonesi, M; Grana, C; Mäcke, HR; Paganelli, G; Rocca, P; Zoboli, S	1
De Camps, J; Jamar, F; Labar, D; Lonneux, M; Mathieu, I; Michel, C; Pauwels, S; Sibomana, M; Walrand, S	1
Dewaraja, Y; Frey, E; Liu, X; Ljungberg, M; Sjögreen, K; Strand, SE	1
Araki, N; Hiraoka, M; Inoue, Y; Kawashita, M; Kim, HM; Kokubo, T; Nagata, Y; Sawada, Y; Shineha, R	1
Zhu, X	1
BROTHERS, M; HART, HE; LASZLO, D; SIEGEL, EP; SPENCER, H	1
EDELSTYN, GA; GLEADHILL, CA; LYONS, AR; RODGERS, HW; TAYLOR, AR; WELBOURN, RB	1
DOGLIOTTI, AM; RUFFO, A	1
CAMANNI, F; MASSARA, F; MOLINATTI, GM; OLIVETTI, M; PIZZINI, A; TEDESCHI, M	1
CHAMBERS, JS	1
FREY, E; MATTER, H; PESTALOZZI, D	1
FREY, E	1
GRADY, ED; NICOLSON, WP; ROLLINS, LC; SALE, W	1
BERINZEI, M; POLANSKI, T; TOT, S; VALD, B; ZOLTAN, L	1
FISHER, M; JONES, JC; WALTER, J	1
WALTER, J	1
FENYES, I; ZOLTAN, L	1
JONES, JC	1
HAYEM, M; JURET, P	1
BLAIR, DW; BROWN, DA; CARTER, PT; FORREST, AP; HARRINGTON, RW; SANDISON, AT; STEWART, HJ; VALENTINE, JM	1
FORREST, AP	1
GROS, C; ROILGEN, A; VLAHOVITCH, B	1
FESANI, F; GOFFRINI, P; PERACCHIA, A	1
DAVIS, FB; DISHER, SC; GOLDIE, H; SMITH, CS	1
DE VOS, WN; IRONSIDE, WM; MOSELEY, RD	1
BECKMANN, R; BORN, W	1
GREENE, WM	1
Boerman, OC; Corstens, FH; Frielink, C; Goldenberg, DM; Oyen, WJ; Postema, EJ; Raemaekers, JM	1
Barrett, J; Bartis, J; Bozarth, J; Edwards, S; Ellars, C; Harris, TD; Kalogeropoulos, S; Lazewatsky, J; Liu, S; Nguyen, T; Onthank, D; Robinson, S; Silva, P; Yalamanchili, P	1
Carlsson, J; Garske, U; Gedda, L; Kairemo, K; Lundqvist, H; Tolmachev, V	1
Barone, R; Borson-Chazot, F; Jamar, F; Krenning, EP; Kvols, LK; Pauwels, S; Valkema, R; Walrand, S	1
Bao, A; Goins, B; Hevezi, JM; Otto, RA; Phillips, WT; Woolley, FR; Zhao, X	1
Imam, SK	1
Chandra, R; Iznaga-Escobar, N; Mishra, AK; Mishra, P; Pnwar, P; Sharma, RK; Srivastava, V	1
Cardillo, TM; Chang, CH; Goldenberg, DM; Horak, ID; Karacay, H; McBride, WJ; Rossi, EA; Sharkey, RM	1
Larson, SM; Pandit-Taskar, N; Wong, CO	1
Macklis, RM; Pohlman, B; Sweetenham, J	1
Chu, DZ; Leong, L; Liu, A; Raubitschek, AA; Shively, JE; Wilczynski, S; Williams, LE; Wong, JY; Wu, AM; Yamauchi, DM; Yazaki, PJ; Zhan, J	1
Buchsbaum, DJ; Meredith, RF	1
Campbell, J; Cheng, V; Fink-Bennett, D; Gates, VL; Lewandowski, RJ; Nagle, C; Qing, F; Salem, R; Savin, M; Sherpa, KM; Thie, J; Wong, CY	1
Al-Nahhas, A; Canelo, R; Habib, N; Jiao, L; Pagou, M; Szyszko, T; Tait, P; Wasan, H	1
Brechbiel, MW; Burns, LJ; Panoskaltsis-Mortari, A; Sicheneder, AR; Taras, EP; Vallera, DA; Vallera, JA	1
Bouchat, V; Lucas, S; Nuttens, VE; Wéra, AC	1
Anderson, TL; Baker, W; Beinlich, UF; Cessna, JT; Divgi, C; Hinkle, GH; Hung, JC; Kowalsky, RJ; Norenberg, JP; Palmer, MR; Petry, N; Ponto, JA; Quinton, T; Rice, PA; Schultz, MK	1
Helmberger, TK; Hoffmann, RT; Jakobs, TF; Reiser, MF; Tatsch, K; Trumm, C	1
Dhami, PS; Jagesia, P; Pandey, U; Pillai, MR; Venkatesh, M	1
Attard, AR; Bradwell, AR; Chappell, MJ	1
DeNardo, GL; DeNardo, SJ; Shen, S	1
DeNardo, DA; DeNardo, GL; DeNardo, SJ; Shen, S; Yuan, A	1
Waldmann, TA	1
Archer, GE; Bigner, DD; Dewhirst, MW; Garg, PK; Schuster, JM; Zalutsky, MR	1
Andersson, BS; Dicke, KA; Quadri, SM; Vriesendorp, HM	1
Nahum, AE	1
Endo, K; Fukushima, Y; Higuchi, T; Hirano, T; Igarashi, H; Inoue, T; Oriuchi, N; Tomiyoshi, K; Watanabe, N; Yukihiro, M	1
Goodwin, DA; Meares, CF	1
Liu, A; Raubitschek, AA; Williams, LE; Wong, JY	1
Albert, R; Bruns, C; Knecht, H; Pless, J; Simeon, C; Smith-Jones, P; Stolz, B	1
Chinol, M; Cremonesi, M; Ferrari, M; Grana, C; Paganelli, G; Prisco, G; Robertson, C; Stabin, MG; Tosi, G	1
Angelberger, P; Bischof, C; Gludovacz, D; Hamilton, G; Kaserer, K; Kofler, A; Leimer, M; Pangerl, T; Peck-Radosavljevic, M; Schlangbauer-Wadl, H; Smith-Jones, PM; Traub, T; Virgolini, I	1
Behe, M; Heppeler, A; Herrmann, R; Jermann, E; Maecke, HR; Muller, J; Otte, A; Powell, P	1
Hahn, K	1
Allegra, C; Brechbiel, M; Carrasquillo, JA; Gansow, O; Hamilton, M; Pai-Scherf, LH; Paik, C; Pastan, I; Pearson, D; Webber, K; Whatley, M; Willingham, MC	1
Chinol, M; Cremonesi, M; Mäcke, HR; Paganelli, G; Zoboli, S	1
Bakker, W; Chen, T; Jamar, F; Krenning, E; Kvols, L; Liu, J; Pauwels, S; Schran, H; Smith, MC; Valkema, R; Yeh, CM	1
de Jong, M; Krenning, EP; Kwekkeboom, D	1
Bartolomei, M; Chinol, M; Cremonesi, M; Ferrari, M; Fiorenza, M; Paganelli, G; Sacco, E; Stabin, MG; Tosi, G	1
Emfietzoglou, D; Kostarelos, K; Sgouros, G	1
Bartolomei, M; Bodei, L; Chinol, M; Cremonesi, M; de Braud, F; De Cicco, C; Ferrari, M; Grana, C; Mäcke, HR; Orsi, F; Paganelli, G; Zoboli, S	1
Begent, RH; Boden, R; Boxer, GM; Flynn, AA; Green, AJ; Pedley, RB	1
Lubberink, M; Lundqvist, H; Tolmachev, V	1
Arnold, R; Becker, W; Béhé, M; Behr, TM; Goldenberg, DM; Gotthardt, M; Gratz, S; Kluge, G; Schipper, ML	1
Bodei, L; Chinol, M; Cremonesi, M; Paganelli, G	1
Britton, K; Buscombe, J; Moncayo, R; Paganelli, G; Riva, P; Virgolini, I	1
Mikheev, NB	1
Dedenkov, AN	1
Courtenay-Luck, NS; Epenetos, AA; Gooden, CS; Kosmas, C; McCall, MJ; Meares, CF; Snook, D	1
Larson, SM	1
Barrett, A; Michalowski, AS; O'Donoghue, JA; Wheldon, TE	1
Tilyou, SM	1
Burton, MA; Egan, G; Fox, RA; Gray, BN; Klemp, PF; Mina, LL	1
Dillehay, LE; Williams, JR	1
Order, SE	2
DeNardo, SJ; Deshpande, SV; Diril, H; Epenetos, AA; Kukis, DL; McCall, MJ; Meares, CF; Moi, MK; Snook, D	1
Epenetos, AA; Hnatowich, DJ; Rowlinson, G; Snook, D; Stewart, S	1
Byrd, BL; Carlton, JE; Crook, JE; Hung, YW; Hwa Sun, TT; Steplewski, ZS; Washburn, LC	1

Reviews

32 review(s) available for yttrium radioisotopes and Neoplasms

Article	Year
Fibroblast Activation Protein Inhibitor Theranostics: Early Clinical Translation. PET clinics, 2023, Volume: 18, Issue:3 Topics: Fibroblasts; Gallium Radioisotopes; Humans; Membrane Proteins; Neoplasms; Positron Emission Tomography Computed Tomography; Precision Medicine; Yttrium Radioisotopes	2023
The evolution of interventional oncology in the 21st century. The British journal of radiology, 2020, Sep-01, Volume: 93, Issue:1113 Topics: Cancer Vaccines; Chemoembolization, Therapeutic; History, 21st Century; Humans; Immunization, Passive; Immunomodulation; Immunotherapy; Immunotherapy, Active; Medical Oncology; Neoplasms; Radiation Oncology; Radiofrequency Ablation; Yttrium Radioisotopes	2020
Microspheres Used in Liver Radioembolization: From Conception to Clinical Effects. Molecules (Basel, Switzerland), 2021, Jun-29, Volume: 26, Issue:13 Topics: Embolization, Therapeutic; Holmium; Humans; Microspheres; Neoplasms; Radiopharmaceuticals; Yttrium Radioisotopes	2021
Radioimmunotherapy: a specific treatment protocol for cancer by cytotoxic radioisotopes conjugated to antibodies. TheScientificWorldJournal, 2014, Volume: 2014 Topics: Antibodies, Monoclonal; Antibodies, Neoplasm; Antineoplastic Agents; Humans; Immunoconjugates; Iodine Radioisotopes; Lymphoma, Non-Hodgkin; Neoplasms; Radioimmunotherapy; Yttrium Radioisotopes	2014
Radionuclide Therapies in Molecular Imaging and Precision Medicine. PET clinics, 2017, Volume: 12, Issue:1 Topics: 3-Iodobenzylguanidine; Humans; Iodine Radioisotopes; Microspheres; Molecular Imaging; Molecular Targeted Therapy; Multimodal Imaging; Neoplasms; Precision Medicine; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Sodium Iodide; Yttrium Radioisotopes	2017
Regional infusion-radioembolization. Surgical oncology clinics of North America, 2008, Volume: 17, Issue:4 Topics: Chemoembolization, Therapeutic; Chemotherapy, Cancer, Regional Perfusion; Clinical Trials as Topic; Humans; Neoplasms; Radiopharmaceuticals; Radiotherapy; Yttrium Radioisotopes	2008
Radioimmunoconjugates in hematopoietic stem cell transplantation. Cancer treatment and research, 2009, Volume: 144 Topics: Disease-Free Survival; Dose-Response Relationship, Radiation; Hematopoietic Stem Cell Transplantation; Humans; Immunoconjugates; Iodine Radioisotopes; Lymphoma; Neoplasms; Recurrence; Remission Induction; Time Factors; Treatment Outcome; Yttrium Radioisotopes	2009
Yttrium-90 (90Y) in the principal radionuclide therapies: an efficacy correlation between peptide receptor radionuclide therapy, radioimmunotherapy and transarterial radioembolization therapy. Ten years of experience (1999-2009). Critical reviews in oncology/hematology, 2011, Volume: 80, Issue:3 Topics: Antibodies, Monoclonal; Carcinoma, Hepatocellular; Clinical Trials as Topic; Embolization, Therapeutic; Humans; Liver Neoplasms; Lymphoma, Non-Hodgkin; Neoplasms; Neuroendocrine Tumors; Radioimmunotherapy; Receptors, Peptide; Treatment Outcome; Yttrium Radioisotopes	2011
Preclinical animal research on therapy dosimetry with dual isotopes. European journal of nuclear medicine and molecular imaging, 2011, Volume: 38 Suppl 1 Topics: Animals; Dose-Response Relationship, Radiation; Drug Evaluation, Preclinical; Indium Radioisotopes; Lutetium; Neoplasms; Radiation Dosage; Radioisotopes; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Rats; Yttrium Radioisotopes	2011
Matched pairs dosimetry: 124I/131I metaiodobenzylguanidine and 124I/131I and 86Y/90Y antibodies. European journal of nuclear medicine and molecular imaging, 2011, Volume: 38 Suppl 1 Topics: 3-Iodobenzylguanidine; Antibodies, Monoclonal; Drug Therapy, Combination; Humans; Iodine Radioisotopes; Neoplasms; Positron-Emission Tomography; Radiation Dosage; Radioimmunotherapy; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes	2011
86Y based PET radiopharmaceuticals: radiochemistry and biological applications. Medicinal chemistry (Shariqah (United Arab Emirates)), 2011, Volume: 7, Issue:5 Topics: Animals; Humans; Neoplasms; Positron-Emission Tomography; Radiochemistry; Radiopharmaceuticals; Yttrium Radioisotopes	2011
PET tracers based on (86)Y. Current radiopharmaceuticals, 2011, Volume: 4, Issue:2 Topics: Animals; Humans; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Yttrium Radioisotopes	2011
Radionuclide therapy beyond radioiodine. Wiener medizinische Wochenschrift (1946), 2012, Volume: 162, Issue:19-20 Topics: Bone Neoplasms; Gamma Rays; Humans; Iodine Radioisotopes; Liver Neoplasms; Lymphoma; Neoplasms; Neuroendocrine Tumors; Palliative Care; Radiation Protection; Radioimmunotherapy; Radioisotopes; Receptors, Somatostatin; Thyroid Neoplasms; Yttrium Radioisotopes	2012
Experience with indium-111 and yttrium-90-labeled somatostatin analogs. Current pharmaceutical design, 2002, Volume: 8, Issue:20 Topics: Heterocyclic Compounds; Humans; Indium Radioisotopes; Neoplasms; Octreotide; Pentetic Acid; Peptides, Cyclic; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Yttrium Radioisotopes	2002
Diagnostic and therapeutic applications of radiolabeled somatostatin analogs: current status in an oncology center. Current pharmaceutical design, 2002, Volume: 8, Issue:20 Topics: Humans; Indium Radioisotopes; Neoplasms; Oncology Service, Hospital; Radioligand Assay; Radionuclide Imaging; Radiopharmaceuticals; Somatostatin; Yttrium Radioisotopes	2002
Practical dosimetry of peptide receptor radionuclide therapy with (90)Y-labeled somatostatin analogs. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2005, Volume: 46 Suppl 1 Topics: Algorithms; Dose-Response Relationship, Radiation; Humans; Neoplasms; Peptides; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Somatostatin; Yttrium Radioisotopes	2005
Molecular nuclear imaging: the radiopharmaceuticals (review). Cancer biotherapy & radiopharmaceuticals, 2005, Volume: 20, Issue:2 Topics: Animals; Annexins; Antibodies, Monoclonal; Antigens; Apoptosis; Cysteine; Diagnostic Imaging; DNA; Fluorodeoxyglucose F18; Glycolysis; Humans; Indium Radioisotopes; Ligands; Lymphoma; Myocardial Infarction; Neoplasms; Octreotide; Organotechnetium Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Technetium; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes	2005
Review of clinical radioimmunotherapy. Expert review of anticancer therapy, 2006, Volume: 6, Issue:3 Topics: Antibodies, Monoclonal; Antibody Formation; Antigens, CD20; Antineoplastic Agents; Clinical Trials as Topic; Humans; Lymphoma, Non-Hodgkin; Neoplasms; Radioimmunotherapy; Radiometry; Stem Cell Transplantation; Transplantation, Autologous; Yttrium Radioisotopes	2006
Pretargeted radioimmunotherapy. International journal of radiation oncology, biology, physics, 2006, Volume: 66, Issue:2 Suppl Topics: Animals; Antibodies, Bispecific; Antibody Specificity; Biotin; Clinical Trials, Phase I as Topic; Humans; Mice; Mice, Nude; Models, Animal; Neoplasms; Radioimmunotherapy; Streptavidin; Transplantation, Heterologous; Yttrium Radioisotopes	2006
[Developments and perspectives in radioablative techniques]. Der Radiologe, 2007, Volume: 47, Issue:12 Topics: Antineoplastic Agents; Brachytherapy; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Neuroendocrine; Chemoembolization, Therapeutic; Colorectal Neoplasms; Combined Modality Therapy; Female; Humans; Liver Neoplasms; Male; Microspheres; Neoplasms; Radiation-Sensitizing Agents; Radiography; Radiology, Interventional; Randomized Controlled Trials as Topic; Yttrium Radioisotopes	2007
Genetically engineered monoclonal antibodies armed with radionuclides. The Year in immunology, 1993, Volume: 7 Topics: Animals; Antibodies, Monoclonal; Autoimmune Diseases; Bismuth; CD4 Antigens; CD4-Positive T-Lymphocytes; Gene Expression Regulation, Neoplastic; Humans; Immunotoxins; Leukemia-Lymphoma, Adult T-Cell; Mice; Neoplasm Proteins; Neoplasms; Protein Engineering; Radioimmunodetection; Radioimmunotherapy; Radioisotopes; Yttrium Radioisotopes	1993
Two approaches for enhancing radioimmunotherapy: alpha emitters and hyperthermia. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1996, Volume: 141 Topics: Alpha Particles; Animals; Antibodies, Monoclonal; Astatine; Humans; Hyperthermia, Induced; Immunoconjugates; Immunoglobulin Fab Fragments; Neoplasms; Radioimmunotherapy; Yttrium Radioisotopes	1996
Hematologic side effects of radiolabeled immunoglobulin therapy. Experimental hematology, 1996, Volume: 24, Issue:10 Topics: Animals; Blood Platelets; Bone Marrow; Granulocytes; Hematopoietic Stem Cells; Humans; Immunoglobulins; Indium Radioisotopes; Iodine Radioisotopes; Neoplasms; Radiography; Radioimmunodetection; Radioimmunotherapy; Yttrium Radioisotopes	1996
Microdosimetry and radiocurability: modelling targeted therapy with beta-emitters. Physics in medicine and biology, 1996, Volume: 41, Issue:10 Topics: Beta Particles; Copper Radioisotopes; Humans; Iodine Radioisotopes; Monte Carlo Method; Neoplasms; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Yttrium Radioisotopes	1996
Monte Carlo-assisted voxel source kernel method (MAVSK) for internal beta dosimetry. Nuclear medicine and biology, 1998, Volume: 25, Issue:4 Topics: Humans; Monte Carlo Method; Neoplasms; Radioimmunotherapy; Radiotherapy Planning, Computer-Assisted; Yttrium Radioisotopes	1998
OctreoTher: ongoing early clinical development of a somatostatin-receptor-targeted radionuclide antineoplastic therapy. Digestion, 2000, Volume: 62 Suppl 1 Topics: Animals; Breast Neoplasms; Carcinoma, Small Cell; Dose-Response Relationship, Radiation; Female; Humans; Indium Radioisotopes; Lung Neoplasms; Male; Mice; Mice, Nude; Neoplasms; Neuroendocrine Tumors; Octreotide; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Yttrium Radioisotopes	2000
Peptide receptor imaging and therapy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2000, Volume: 41, Issue:10 Topics: Humans; Indium Radioisotopes; Neoplasms; Neuroendocrine Tumors; Octreotide; Oligopeptides; Pentetic Acid; Radiopharmaceuticals; Receptors, Somatostatin; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes	2000
Radioactive colloidal solutions and suspensions for medical use. Atomic energy review, 1976, Volume: 14, Issue:1 Topics: Colloids; Drug Stability; Gallium Radioisotopes; Gold Colloid, Radioactive; Humans; Indium; Iodine Radioisotopes; Isotope Labeling; Lung Diseases; Mononuclear Phagocyte System; Neoplasms; Phosphorus Radioisotopes; Quaternary Ammonium Compounds; Radioisotopes; Radionuclide Imaging; Rhenium; Serum Albumin, Radio-Iodinated; Suspensions; Technetium; Yttrium Radioisotopes	1976
The curability of tumours of differing size by targeted radiotherapy using 131I or 90Y. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1991, Volume: 21, Issue:2 Topics: Beta Particles; Dose-Response Relationship, Radiation; Humans; Iodine Radioisotopes; Models, Theoretical; Neoplasms; Prognosis; Yttrium Radioisotopes	1991
Radiobiology of dose-rate patterns achievable in radioimmunoglobulin therapy. Frontiers of radiation therapy and oncology, 1990, Volume: 24 Topics: Carcinoma, Hepatocellular; Dose-Response Relationship, Radiation; Humans; Immunization, Passive; Liver Neoplasms; Neoplasms; Yttrium Radioisotopes	1990
The theoretical implications and experimental and clinical results of radiolabeled antiferritin. Acta oncologica (Stockholm, Sweden), 1990, Volume: 29, Issue:6 Topics: Animals; Antibodies, Monoclonal; Brachytherapy; Combined Modality Therapy; Ferritins; Humans; Iodine Radioisotopes; Models, Biological; Neoplasms; Yttrium Radioisotopes	1990
Preparation and use of DTPA-coupled antitumor antibodies radiolabeled with yttrium-90. Targeted diagnosis and therapy, 1988, Volume: 1 Topics: Animals; Antibodies, Monoclonal; Drug Carriers; Humans; Mice; Mice, Nude; Neoplasms; Pentetic Acid; Yttrium Radioisotopes	1988

Trials

12 trial(s) available for yttrium radioisotopes and Neoplasms

Article	Year
Phase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancer. British journal of cancer, 2014, Jul-15, Volume: 111, Issue:2 Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Cohort Studies; Deoxycytidine; Embolization, Therapeutic; Female; Fluorouracil; Humans; Male; Maximum Tolerated Dose; Microspheres; Middle Aged; Neoplasms; Prospective Studies; Yttrium Radioisotopes	2014
Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study. European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:2 Topics: Adult; Aged; Amino Acids; Biomarkers, Tumor; Blood Platelets; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Hemoglobins; Humans; Kidney; Lymphocytes; Male; Maximum Tolerated Dose; Metabolic Clearance Rate; Middle Aged; Nausea; Neoplasms; Octreotide; Radiation-Protective Agents; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Renal Insufficiency; Vomiting; Yttrium Radioisotopes	2003
A phase I trial of (90)Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignancies. Cancer biotherapy & radiopharmaceuticals, 2006, Volume: 21, Issue:2 Topics: Adult; Aged; Antibodies, Monoclonal; Carcinoembryonic Antigen; Female; Heterocyclic Compounds, 1-Ring; Humans; Immunoglobulin G; Immunotoxins; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Radioimmunotherapy; Yttrium Radioisotopes	2006
Regional yttrium-90 microsphere treatment of surgically unresectable and chemotherapy-refractory metastatic liver carcinoma. Cancer biotherapy & radiopharmaceuticals, 2006, Volume: 21, Issue:4 Topics: Aged; Aged, 80 and over; Citrates; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasms; Organometallic Compounds; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Yttrium Radioisotopes	2006
Three-step radioimmunotherapy with yttrium-90 biotin: dosimetry and pharmacokinetics in cancer patients. European journal of nuclear medicine, 1999, Volume: 26, Issue:2 Topics: Antibodies, Monoclonal; Avidin; Biotinylation; Bone Marrow; Chelating Agents; Heterocyclic Compounds, 1-Ring; Humans; Kidney; Liver; Models, Biological; Neoplasms; Pentetic Acid; Radioimmunotherapy; Radiopharmaceuticals; Radiotherapy Dosage; Streptavidin; Tomography, Emission-Computed; Urinary Bladder; Whole-Body Counting; Yttrium Radioisotopes	1999
Imaging and phase I study of 111In- and 90Y-labeled anti-LewisY monoclonal antibody B3. Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:5 Topics: Adult; Aged; Animals; Antibodies, Monoclonal; Area Under Curve; Female; Hematologic Diseases; Humans; Indium Radioisotopes; Lewis Blood Group Antigens; Male; Metabolic Clearance Rate; Mice; Middle Aged; Neoplasms; Radionuclide Imaging; Tissue Distribution; Treatment Outcome; Yttrium Radioisotopes	2000
Receptor-mediated radionuclide therapy with 90Y-DOTA-D-Phe1-Tyr3-Octreotide: preliminary report in cancer patients. Cancer biotherapy & radiopharmaceuticals, 1999, Volume: 14, Issue:6 Topics: Adult; Aged; Female; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasms; Octreotide; Pancreatic Neoplasms; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed; Yttrium Radioisotopes	1999
Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide. European journal of nuclear medicine, 2001, Volume: 28, Issue:4 Topics: Adult; Aged; Female; Humans; Indicators and Reagents; Male; Middle Aged; Neoplasms; Octreotide; Radiometry; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Tissue Distribution; Tomography, X-Ray Computed; Yttrium Radioisotopes	2001
Receptor-mediated radiotherapy with Y-DOTA-DPhe-Tyr-octreotide: the experience of the European Institute of Oncology Group. Seminars in nuclear medicine, 2002, Volume: 32, Issue:2 Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Neoplasms; Octreotide; Radiopharmaceuticals; Receptors, Somatostatin; Yttrium Radioisotopes	2002
In- and Y-DOTA-lanreotide: results and implications of the MAURITIUS trial. Seminars in nuclear medicine, 2002, Volume: 32, Issue:2 Topics: Heterocyclic Compounds; Humans; Indium Radioisotopes; Neoplasms; Peptides, Cyclic; Radiopharmaceuticals; Receptors, Somatostatin; Yttrium Radioisotopes	2002
Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy. Cancer research, 1992, Feb-15, Volume: 52, Issue:4 Topics: Aged; Antibodies; Antibodies, Monoclonal; Antibody Formation; Breast; Breast Neoplasms; Chelating Agents; Drug Evaluation; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Male; Middle Aged; Neoplasm Staging; Neoplasms; Ovarian Neoplasms; Radioimmunotherapy; Radionuclide Imaging; Stomach Neoplasms; Testicular Neoplasms; Yttrium Radioisotopes	1992
International Clinical Trials in Radiation Oncology. Isotopic immunotherapy: radiolabelled antibody. International journal of radiation oncology, biology, physics, 1988, Volume: 14 Suppl 1 Topics: Antibodies; Clinical Trials as Topic; Ferritins; Hodgkin Disease; Humans; International Cooperation; Iodine Radioisotopes; Neoplasms; Radioisotopes; Yttrium Radioisotopes	1988

Other Studies

89 other study(ies) available for yttrium radioisotopes and Neoplasms

Article	Year
Hepatic Abscess following Yttrium-90 Radioembolization in Patients with Surgical Bilioenteric Anastomosis or Compromised Sphincter of Oddi: A Tertiary Cancer Center Experience. Current oncology (Toronto, Ont.), 2022, 09-28, Volume: 29, Issue:10 Topics: Adult; Aged; Anastomosis, Surgical; Female; Humans; Liver Abscess; Male; Middle Aged; Neoplasms; Sphincter of Oddi; Yttrium Radioisotopes	2022
Yttrium-90 radiation segmentectomy for hepatic metastases: A multi-institutional study of safety and efficacy. Journal of surgical oncology, 2021, Volume: 123, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms; Prognosis; Retrospective Studies; Survival Rate; Yttrium Radioisotopes	2021
Radiation Safety for Yttrium-90-polymer Composites (RadioGel™) in Therapy of Solid Tumors. Health physics, 2021, 05-01, Volume: 120, Issue:5 Topics: Animals; Cats; Dogs; Neoplasms; Polymers; Rabbits; Radioimmunotherapy; Tissue Distribution; X-Ray Microtomography; Yttrium Radioisotopes	2021
Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy. Radiation research, 2018, Volume: 190, Issue:3 Topics: Actinium; Alpha Particles; Beta Particles; Bismuth; Dose-Response Relationship, Radiation; Humans; Lead Radioisotopes; Lutetium; Neoplasm Metastasis; Neoplasms; Radioisotopes; Yttrium Radioisotopes	2018
The Physics of Radioisotope Treatment Is Not Always the Same. Journal of the American College of Radiology : JACR, 2018, Volume: 15, Issue:8 Topics: Clinical Competence; Diagnostic Imaging; Health Physics; Humans; Iodine Radioisotopes; Neoplasms; Radiotherapy Dosage; Yttrium Radioisotopes	2018
Patient Radiation Exposure in Transradial versus Transfemoral Yttrium-90 Radioembolization: A Retrospective Propensity Score-Matched Analysis. Journal of vascular and interventional radiology : JVIR, 2018, Volume: 29, Issue:7 Topics: Aged; Catheterization, Peripheral; Embolization, Therapeutic; Female; Femoral Artery; Humans; Male; Middle Aged; Neoplasms; Patient Safety; Propensity Score; Radial Artery; Radiation Dosage; Radiation Exposure; Retrospective Studies; Risk Factors; Time Factors; Yttrium Radioisotopes	2018
EANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations. European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:13 Topics: Algorithms; Humans; Neoplasms; Practice Guidelines as Topic; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Uncertainty; Yttrium Radioisotopes	2018
Introduction to Issue on Yttrium-90 Radioembolization. Techniques in vascular and interventional radiology, 2019, Volume: 22, Issue:2 Topics: Embolization, Therapeutic; Humans; Neoplasms; Radiopharmaceuticals; Treatment Outcome; Yttrium Radioisotopes	2019
Radioactive synovectomy with (90) yttrium and (153) samarium hydroxyapatite in haemophilic joints: preliminary study on radiation safety. Haemophilia : the official journal of the World Federation of Hemophilia, 2013, Volume: 19, Issue:4 Topics: Adolescent; Adult; Child; Child, Preschool; Female; Health Surveys; Hemophilia A; Humans; Hydroxyapatites; Joints; Male; Middle Aged; Neoplasms; Radionuclide Imaging; Samarium; Synovial Membrane; Young Adult; Yttrium Radioisotopes	2013
Monte Carlo characterization of biocompatible beta-emitting 90Y glass seed incorporated with the radionuclide 153Sm as a SPECT marker for brachytherapy applications. Journal of applied clinical medical physics, 2013, Sep-06, Volume: 14, Issue:5 Topics: Anisotropy; Beta Particles; Biocompatible Materials; Brachytherapy; Humans; Monte Carlo Method; Neoplasms; Phantoms, Imaging; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Samarium; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes	2013
Cerenkov luminescence imaging of αv β6 integrin expressing tumors using (90) Y-labeled peptides. Journal of labelled compounds & radiopharmaceuticals, 2014, Volume: 57, Issue:9 Topics: Animals; Antigens, Neoplasm; Integrins; Luminescence; Male; Mice; Neoplasms; Peptide Fragments; Protein Binding; Radiography; Radiopharmaceuticals; Tissue Distribution; Viral Envelope Proteins; Yttrium Radioisotopes	2014
Comparison of internal dose estimates obtained using organ-level, voxel S value, and Monte Carlo techniques. Medical physics, 2014, Volume: 41, Issue:9 Topics: Algorithms; Computer Simulation; Female; Humans; Iodine Radioisotopes; Kidney; Liver; Lutetium; Male; Models, Biological; Monte Carlo Method; Neoplasms; Niacinamide; Octreotide; Radiation Dosage; Radiopharmaceuticals; Software; Technetium; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes	2014
[PET radiopharmaceuticals: novelties and new possibilities]. Magyar onkologia, 2014, Volume: 58, Issue:4 Topics: Carbon Radioisotopes; Copper Radioisotopes; Electrons; Fluorine Radioisotopes; Gallium Radioisotopes; Half-Life; Humans; Neoplasms; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Scandium; Yttrium Radioisotopes; Zirconium	2014
Impairment of lymphocyte function following yttrium-90 DOTATOC therapy. Cancer immunology, immunotherapy : CII, 2015, Volume: 64, Issue:6 Topics: Adult; Aged; Female; Humans; Lymphocytes; Male; Middle Aged; Neoplasms; Octreotide; Radiation Injuries; Receptors, Somatostatin; Young Adult; Yttrium Radioisotopes	2015
Beyond 18F-FDG: Characterization of PET/CT and PET/MR Scanners for a Comprehensive Set of Positron Emitters of Growing Application--18F, 11C, 89Zr, 124I, 68Ga, and 90Y. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:8 Topics: Carbon Radioisotopes; Contrast Media; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Tomography, X-Ray Computed; Yttrium Radioisotopes; Zirconium	2015
Monte Carlo Calculation of Radioimmunotherapy with (90)Y-, (177)Lu-, (131)I-, (124)I-, and (188)Re-Nanoobjects: Choice of the Best Radionuclide for Solid Tumour Treatment by Using TCP and NTCP Concepts. Computational and mathematical methods in medicine, 2015, Volume: 2015 Topics: Algorithms; Antibodies, Monoclonal; Carcinoma, Non-Small-Cell Lung; Computer Simulation; Humans; Iodine Radioisotopes; Lung; Lung Neoplasms; Lutetium; Models, Statistical; Monte Carlo Method; Nanomedicine; Neoplasms; Radiation Pneumonitis; Radioimmunotherapy; Radioisotopes; Radiotherapy Planning, Computer-Assisted; Rhenium; Yttrium Radioisotopes	2015
Is there a correlation between planar scintigraphy after 99mTc-MAA and 90Y administration? Nuclear medicine communications, 2016, Volume: 37, Issue:2 Topics: Humans; Neoplasms; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes	2016
Targeted radionuclide therapy. Medical physics, 2008, Volume: 35, Issue:7 Topics: Bone Marrow; Gamma Cameras; Humans; Iodine Radioisotopes; Medical Oncology; Neoplasms; Phantoms, Imaging; Positron-Emission Tomography; Radiation Oncology; Radioimmunotherapy; Radioisotopes; Radiotherapy Dosage; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Yttrium Radioisotopes	2008
Estimates of radiation-absorbed dose to kidneys in patients treated with 90Y-ibritumomab tiuxetan. Cancer biotherapy & radiopharmaceuticals, 2008, Volume: 23, Issue:5 Topics: Antibodies, Monoclonal; Body Weight; Female; Humans; Kidney; Kinetics; Neoplasms; Radiation Dosage; Radioimmunotherapy; Radiometry; Radionuclide Imaging; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Whole Body Imaging; Yttrium Radioisotopes	2008
(177)Lu- labeled MOv18 as compared to (131)I- or (90)Y-labeled MOv18 has the better therapeutic effect in eradication of alpha folate receptor-expressing tumor xenografts. Nuclear medicine and biology, 2009, Volume: 36, Issue:7 Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Carrier Proteins; Cell Line, Tumor; Female; Folate Receptors, GPI-Anchored; Gene Expression Regulation, Neoplastic; Humans; Iodine Radioisotopes; Isotope Labeling; Lutetium; Maximum Tolerated Dose; Mice; Neoplasms; Radioimmunotherapy; Radioisotopes; Receptors, Cell Surface; Time Factors; Tissue Distribution; Transplantation, Heterologous; Tumor Burden; Yttrium Radioisotopes	2009
PET imaging of HER1-expressing xenografts in mice with 86Y-CHX-A''-DTPA-cetuximab. European journal of nuclear medicine and molecular imaging, 2010, Volume: 37, Issue:7 Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cell Line, Tumor; Cell Transformation, Neoplastic; Cetuximab; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Humans; Isothiocyanates; Mice; Neoplasms; Pentetic Acid; Positron-Emission Tomography; Radiochemistry; Yttrium Radioisotopes	2010
Preparation, biological evaluation, and pharmacokinetics of the human anti-HER1 monoclonal antibody panitumumab labeled with 86Y for quantitative PET of carcinoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2010, Volume: 51, Issue:6 Topics: Animals; Antibodies, Monoclonal; Area Under Curve; Biological Transport; Cell Line, Tumor; Cell Transformation, Neoplastic; ErbB Receptors; Female; Humans; Mice; Neoplasms; Panitumumab; Pentetic Acid; Positron-Emission Tomography; Radiochemistry; Risk Assessment; Yttrium Radioisotopes	2010
Two ⁹⁰Y-labeled multimeric RGD peptides RGD4 and 3PRGD2 for integrin targeted radionuclide therapy. Molecular pharmaceutics, 2011, Apr-04, Volume: 8, Issue:2 Topics: Animals; Dimerization; Female; Fluorescent Antibody Technique; Humans; Indium Radioisotopes; Integrin alphaVbeta3; Maximum Tolerated Dose; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Oligopeptides; Radiopharmaceuticals; Substrate Specificity; Technetium; Tissue Distribution; Tomography, Emission-Computed; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Yttrium Radioisotopes	2011
Embolisation of the gastroduodenal artery is not necessary in the presence of reversed flow before yttrium-90 radioembolisation. Cardiovascular and interventional radiology, 2012, Volume: 35, Issue:4 Topics: Angiography; Cross-Sectional Studies; Dose-Response Relationship, Radiation; Duodenum; Embolization, Therapeutic; Female; Humans; Male; Microspheres; Middle Aged; Neoplasms; Radiopharmaceuticals; Retrospective Studies; Stomach; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Whole Body Imaging; Yttrium Radioisotopes	2012
The significance of bremsstrahlung SPECT/CT after yttrium-90 radioembolization treatment in the prediction of extrahepatic side effects. European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Embolization, Therapeutic; Female; Humans; Male; Microspheres; Middle Aged; Multimodal Imaging; Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Yttrium Radioisotopes	2012
Three-dimensional patient-specific dosimetry in radioimmunotherapy with 90Y-ibritumomab-tiuxetan. Cancer biotherapy & radiopharmaceuticals, 2012, Volume: 27, Issue:2 Topics: Antibodies, Monoclonal; Humans; Imaging, Three-Dimensional; Monte Carlo Method; Neoplasms; Phantoms, Imaging; Radioimmunotherapy; Radiometry; Radiotherapy Planning, Computer-Assisted; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes	2012
Pulsed high intensity focused ultrasound increases penetration and therapeutic efficacy of monoclonal antibodies in murine xenograft tumors. Journal of controlled release : official journal of the Controlled Release Society, 2012, Aug-20, Volume: 162, Issue:1 Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Humans; Immunoconjugates; Mice; Mice, Nude; Neoplasms; Radioimmunotherapy; Transplantation, Heterologous; Ultrasonic Therapy; Yttrium Radioisotopes	2012
Immuno-SPET/CT and immuno-PET/CT: a step ahead to translational imaging. Clinical & experimental metastasis, 2012, Volume: 29, Issue:7 Topics: Copper Radioisotopes; Humans; Iodine Radioisotopes; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Radioimmunodetection; Radioimmunotherapy; Radioisotopes; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Yttrium Radioisotopes; Zirconium	2012
[Radionuclide therapy for cancer--what's new?]. Duodecim; laaketieteellinen aikakauskirja, 2012, Volume: 128, Issue:21 Topics: Embolization, Therapeutic; Female; Finland; Humans; Iodine Radioisotopes; Liver Neoplasms; Male; Neoplasms; Neuroendocrine Tumors; Octreotide; Paraganglioma; Pheochromocytoma; Prostatic Neoplasms; Radiotherapy; Thyroid Neoplasms; Yttrium Radioisotopes	2012
Radiation dose distributions in normal tissue adjacent to tumors containing (131)I or (90)Y: the potential for toxicity. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002, Volume: 43, Issue:8 Topics: Computer Simulation; Humans; Iodine Radioisotopes; Monte Carlo Method; Neoplasms; Radiation Dosage; Radiotherapy Dosage; Yttrium Radioisotopes	2002
Quantitation in PET using isotopes emitting prompt single gammas: application to yttrium-86. European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:3 Topics: Algorithms; Gamma Rays; Humans; Maximum Allowable Concentration; Models, Biological; Neoplasms; Organ Specificity; Quality Control; Radiopharmaceuticals; Radiotherapy Dosage; Receptors, Somatostatin; Tissue Distribution; Tomography, Emission-Computed; Whole-Body Counting; Yttrium Radioisotopes	2003
3D absorbed dose calculations based on SPECT: evaluation for 111-In/90-Y therapy using Monte Carlo simulations. Cancer biotherapy & radiopharmaceuticals, 2003, Volume: 18, Issue:1 Topics: Humans; Indium Radioisotopes; Monte Carlo Method; Neoplasms; Radiotherapy Dosage; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes	2003
Preparation of ceramic microspheres for in situ radiotherapy of deep-seated cancer. Biomaterials, 2003, Volume: 24, Issue:17 Topics: Brachytherapy; Ceramics; Coated Materials, Biocompatible; Humans; Injections; Materials Testing; Microspheres; Neoplasms; Particle Size; Radiopharmaceuticals; Yttrium; Yttrium Radioisotopes	2003
Radiation safety considerations with therapeutic 90Y Zevalin. Health physics, 2003, Volume: 85, Issue:2 Suppl Topics: Antibodies, Monoclonal; Calibration; Humans; Neoplasms; Occupational Exposure; Radiation Protection; Radioimmunotherapy; Time Factors; Yttrium Radioisotopes	2003
Radioyttrium (Y90) for the palliative treatment of effusions due to malignancy. Journal of the American Medical Association, 1956, Jun-09, Volume: 161, Issue:6 Topics: Exudates and Transudates; Humans; Neoplasms; Palliative Care; Radioactivity; Yttrium; Yttrium Radioisotopes	1956
Hypophysectomy combined with intrasellar irradiation with yttrium-90. Lancet (London, England), 1958, Mar-01, Volume: 1, Issue:7018 Topics: Breast; Breast Neoplasms; Humans; Hypophysectomy; Mastectomy; Neoplasms; Yttrium; Yttrium Radioisotopes	1958
[Interstitial irradiation of the pituitary gland with yttrium 90; indications, technic and results]. Minerva medica, 1958, Jun-16, Volume: 49, Issue:48 Topics: Humans; Neoplasms; Pituitary Gland; Yttrium; Yttrium Radioisotopes	1958
[Biochemical and hormonal changes in humans after intrasellar insertion of yttrium 90]. Minerva chirurgica, 1958, Oct-31, Volume: 13, Issue:20 Topics: Adrenal Cortex; Gonadotropins; Gonadotropins, Pituitary; Humans; Neoplasms; Phosphorus; Pituitary Gland; Sella Turcica; Thyroid Gland; Yttrium; Yttrium Radioisotopes	1958
A case of metastasizing chorionepithelioma treated by local excision and pituitary ablation with yttrium 90. The Journal of obstetrics and gynaecology of the British Commonwealth, 1961, Volume: 68 Topics: Choriocarcinoma; Female; Humans; Medical Records; Neoplasms; Pituitary Gland; Pregnancy; Radioactivity; Vaginal Neoplasms; Yttrium; Yttrium Radioisotopes	1961
[Transnasal implantation of a predominantly suprasellar hypophysial tumor with yttrium 90 rods]. Strahlentherapie, 1961, Volume: 114 Topics: Humans; Neoplasms; Pituitary Gland; Pituitary Neoplasms; Radioactivity; Skull; Yttrium; Yttrium Radioisotopes	1961
[Indications, technic and limitations of the transnasal implantation of radioisotopes in a pituitary tumor]. Radiologia clinica, 1960, Volume: 29 Topics: Humans; Neoplasms; Pituitary Gland; Pituitary Neoplasms; Radioactivity; Radioisotopes; Yttrium; Yttrium Radioisotopes	1960
Intra-arterial radioisotopes to treat cancer. The American surgeon, 1960, Volume: 26 Topics: Humans; Neoplasms; Neoplasms, Experimental; Radioisotopes; Yttrium; Yttrium Radioisotopes	1960
[Therapy of generalized forms of malignant tumors by the method of administration of Y90 into the hypophysis]. Voprosy onkologii, 1960, Volume: 6(10) Topics: Humans; Neoplasms; Pituitary Gland; Yttrium; Yttrium Radioisotopes	1960
Radioactive colloidal yttrium silicate in the treatment of malignant effusions. I. Clinical aspects and investigations. The British journal of radiology, 1961, Volume: 34 Topics: Humans; Neoplasms; Radioactivity; Silicates; Yttrium; Yttrium Radioisotopes	1961
Malignant effusions treated by colloidal radioactive yttrium silicate. British medical journal, 1960, Oct-29, Volume: 2, Issue:5208 Topics: Exudates and Transudates; Humans; Neoplasms; Pleural Effusion, Malignant; Silicates; Yttrium; Yttrium Radioisotopes	1960
Stereotactic diagnosis and radioactive treatment in a case of spheno-occipital chordoma. Journal of neurosurgery, 1960, Volume: 17 Topics: Brain Neoplasms; Chordoma; Humans; Neoplasms; Occipital Lobe; Supratentorial Neoplasms; Yttrium; Yttrium Radioisotopes	1960
Radioactive colloidal yttrium silicate in the treatment of malignant effusions. II. Calculations of tissue dosage. The British journal of radiology, 1961, Volume: 34 Topics: Humans; Neoplasms; Radioactivity; Silicates; Yttrium; Yttrium Radioisotopes	1961
[Implantation of intrapituitary radioactive material (Au-198 and Y-90) in metastatic cancers of the breast. Clinical and biological review apropos of 75 cases]. Revue francaise d'etudes cliniques et biologiques, 1961, Volume: 6 Topics: Breast; Breast Neoplasms; Gold Radioisotopes; Humans; Hypophysectomy; Neoplasms; Neoplasms, Second Primary; Yttrium; Yttrium Radioisotopes	1961
Radio-active implantation of the pituitary. The British journal of surgery, 1959, Volume: 47 Topics: Humans; Neoplasms; Pituitary Gland; Yttrium; Yttrium Radioisotopes	1959
Treatment of advanced breast cancer by yttrium-90 implantation of the pituitary. Acta - Unio Internationalis Contra Cancrum, 1959, Volume: 15 Topics: Breast; Breast Neoplasms; Humans; Neoplasms; Pituitary Diseases; Yttrium; Yttrium Radioisotopes	1959
[Hypophysectomy for cancer. Surgical method. Stereotaxic method. Comparative study of 28 cases]. Annales de chirurgie, 1960, Volume: 14 Topics: Hypophysectomy; Neoplasms; Radioactivity; Stereotaxic Techniques; Yttrium; Yttrium Radioisotopes	1960
[Implantation of radioactive yttrium (Y90) in the sella turcica in the treatment of breast and prostate carcinoma in the advanced stage (considerations on 21 cases)]. Archivio italiano di chirurgia, 1959, Volume: 85 Topics: Breast; Breast Neoplasms; Humans; Hypophysectomy; Male; Neoplasms; Prostatic Neoplasms; Sella Turcica; Yttrium; Yttrium Radioisotopes	1959
Prevention of peritoneal free (ascites) tumor cell growth and implantation by pretreatment with radioactive yttrium. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1959, Volume: 102 Topics: Animals; Ascites; Cell Proliferation; Humans; Neoplasms; Neoplasms, Experimental; Peritoneum; Yttrium; Yttrium Radioisotopes	1959
Yttrium implantation of the hypophysis by the nasal route. Acta - Unio Internationalis Contra Cancrum, 1959, Volume: 15 Topics: Humans; Neoplasms; Pituitary Gland; Yttrium; Yttrium Radioisotopes	1959
[The current radiotherapy of hemangioma on the basis of the premature infant as an example]. Munchener medizinische Wochenschrift (1950), 1962, Aug-24, Volume: 104 Topics: Child; Hemangioma; Humans; Infant; Infant, Newborn; Infant, Premature; Neoplasms; Radioactivity; Strontium; Strontium Radioisotopes; Yttrium; Yttrium Radioisotopes	1962
EMBOLIZATION OF DOG PROSTATES WITH YTTRIUM-90 MICROSPHERES. The Journal of urology, 1963, Volume: 90 Topics: Dogs; Embolism; Embolization, Therapeutic; Humans; Male; Microspheres; Neoplasms; Prostatic Neoplasms; Radiation Protection; Research; Yttrium; Yttrium Radioisotopes	1963
Biodistribution of 131I-, 186Re-, 177Lu-, and 88Y-labeled hLL2 (Epratuzumab) in nude mice with CD22-positive lymphoma. Cancer biotherapy & radiopharmaceuticals, 2003, Volume: 18, Issue:4 Topics: Analysis of Variance; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD; Antigens, Differentiation, B-Lymphocyte; Cell Adhesion Molecules; Duodenum; Female; Femur; Humans; Iodine Radioisotopes; Kidney; Lectins; Liver; Lung; Lutetium; Lymphoma; Mice; Mice, Inbred BALB C; Mice, Nude; Muscles; Neoplasm Transplantation; Neoplasms; Radioimmunotherapy; Radioisotopes; Rhenium; Sialic Acid Binding Ig-like Lectin 2; Spleen; Time Factors; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Yttrium Radioisotopes	2003
Design, synthesis, and evaluation of radiolabeled integrin alpha v beta 3 receptor antagonists for tumor imaging and radiotherapy. Cancer biotherapy & radiopharmaceuticals, 2003, Volume: 18, Issue:4 Topics: Adenocarcinoma; Animals; beta-Alanine; Binding, Competitive; Cell-Matrix Junctions; Dose-Response Relationship, Radiation; Drug Design; Female; Fibrinogen; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Integrin alpha5beta1; Integrin alphaVbeta3; Integrins; Jurkat Cells; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Neoplasms; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Radioisotopes; Radionuclide Imaging; Receptors, Vitronectin; Sulfonamides; Tissue Distribution; Vitronectin; Yttrium Radioisotopes	2003
[Radionuclide therapy--a possible way toward an improved treatment of cancer. The obstacle is the shortage of commercially available radionuclides for clinical use]. Lakartidningen, 2004, Mar-11, Volume: 101, Issue:11 Topics: Humans; Iodine Radioisotopes; Neoplasms; Radioisotopes; Yttrium Radioisotopes	2004
Theoretical study of the influence of a heterogeneous activity distribution on intratumoral absorbed dose distribution. Medical physics, 2005, Volume: 32, Issue:1 Topics: Algorithms; Diffusion; Fourier Analysis; Humans; Imaging, Three-Dimensional; Monte Carlo Method; Neoplasms; Phantoms, Imaging; Radioimmunotherapy; Radioisotopes; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Yttrium Radioisotopes	2005
Radiolabeling and biological evaluation of DOTA-Ph-Al derivative conjugated to anti-EGFR antibody ior egf/r3 for targeted tumor imaging and therapy. Cancer biology & therapy, 2005, Volume: 4, Issue:8 Topics: Acetamides; Animals; Antibodies, Monoclonal; Cell Line, Tumor; Diagnostic Imaging; ErbB Receptors; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Isotope Labeling; Mice; Mice, Inbred BALB C; Neoplasms; Radioimmunotherapy; Yttrium Radioisotopes	2005
Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Oct-01, Volume: 11, Issue:19 Pt 2 Topics: Animals; Antibodies, Monoclonal; Avidin; Biotin; Calibration; Cell Line, Tumor; Contrast Media; DNA; DNA, Complementary; Drug Delivery Systems; Female; Gamma Rays; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Mice; Mice, Nude; Models, Biological; Neoplasm Transplantation; Neoplasms; Oligonucleotides; Radioimmunodetection; Radioimmunotherapy; Radioisotopes; Radionuclide Imaging; Recombinant Proteins; Streptavidin; Time Factors; Ultrasonics; Yttrium Radioisotopes	2005
JNM supplement on molecular radiotherapy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2005, Volume: 46, Issue:10 Topics: Drug Approval; Drug Delivery Systems; Humans; Microspheres; Molecular Biology; Neoplasms; Radioimmunotherapy; Radiopharmaceuticals; Yttrium Radioisotopes	2005
Assessment of response to treatment of unresectable liver tumours with 90Y microspheres: value of FDG PET versus computed tomography. Nuclear medicine communications, 2007, Volume: 28, Issue:1 Topics: Adult; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes	2007
Radiotherapy of CD45-expressing Daudi tumors in nude mice with yttrium-90-labeled, PEGylated anti-CD45 antibody. Cancer biotherapy & radiopharmaceuticals, 2007, Volume: 22, Issue:4 Topics: Animals; Antibodies; Body Weight; Cell Line, Tumor; Chromatography, Ion Exchange; Humans; Immunotherapy; Leukocyte Common Antigens; Mice; Mice, Nude; Molecular Weight; Neoplasms; Polyethylene Glycols; Xenograft Model Antitumor Assays; Yttrium Radioisotopes	2007
Determination of biological vector characteristics and nanoparticle dimensions for radioimmunotherapy with radioactive nanoparticles. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2008, Volume: 66, Issue:2 Topics: Humans; Metal Nanoparticles; Neoplasms; Palladium; Phosphorus Radioisotopes; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Yttrium Radioisotopes	2008
A performance evaluation of 90Y dose-calibrator measurements in nuclear pharmacies and clinics in the United States. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2008, Volume: 66, Issue:2 Topics: Ambulatory Care Facilities; Antibodies, Monoclonal; Humans; Neoplasms; Nuclear Medicine; Pharmacies; Pilot Projects; Quality Control; Radioimmunotherapy; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Reference Standards; United States; Yttrium Radioisotopes	2008
Extraction paper chromatography technique for the radionuclidic purity evaluation of 90Y for clinical use. Analytical chemistry, 2008, Feb-01, Volume: 80, Issue:3 Topics: Body Burden; Chelating Agents; Chromatography, Paper; Humans; Neoplasms; Organophosphonates; Radionuclide Imaging; Reproducibility of Results; Scintillation Counting; Sensitivity and Specificity; Solvents; Strontium Radioisotopes; Yttrium Radioisotopes	2008
Model based calculation for effective cancer radioimmunotherapy. The British journal of radiology, 1995, Volume: 68, Issue:810 Topics: Antibody Affinity; Humans; Immunoglobulin Fragments; Immunoglobulin G; Iodine Radioisotopes; Models, Immunological; Models, Theoretical; Neoplasms; Radiation Dosage; Radioimmunotherapy; Radiotherapy Dosage; Yttrium Radioisotopes	1995
Quantitative bremsstrahlung imaging of yttrium-90 using a Wiener filter. Medical physics, 1994, Volume: 21, Issue:9 Topics: Gamma Rays; Humans; Liver; Models, Theoretical; Neoplasms; Radioimmunotherapy; Radionuclide Imaging; Spleen; Yttrium Radioisotopes	1994
Planar gamma camera imaging and quantitation of yttrium-90 bremsstrahlung. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1994, Volume: 35, Issue:8 Topics: Beta Particles; Humans; Models, Structural; Neoplasms; Radioimmunotherapy; Radiometry; Radionuclide Imaging; Radiotherapy Dosage; Scattering, Radiation; Sensitivity and Specificity; Yttrium Radioisotopes	1994
Preparation of yttrium-90-labeled human macroaggregated albumin for regional radiotherapy. Nuclear medicine and biology, 1997, Volume: 24, Issue:5 Topics: Albumins; Animals; Brachytherapy; Humans; Mice; Mice, Nude; Neoplasms; Tissue Distribution; Tumor Cells, Cultured; Yttrium Radioisotopes	1997
Pretargeting: general principles; October 10-12, 1996. Cancer, 1997, Dec-15, Volume: 80, Issue:12 Suppl Topics: Animals; Humans; Mice; Neoplasms; Radioimmunodetection; Radioimmunotherapy; Yttrium Radioisotopes	1997
Direct synthesis of [DOTA-DPhe1]-octreotide and [DOTA-DPhe1,Tyr3]-octreotide (SMT487): two conjugates for systemic delivery of radiotherapeutical nuclides to somatostatin receptor positive tumors in man. Bioorganic & medicinal chemistry letters, 1998, May-19, Volume: 8, Issue:10 Topics: Drug Carriers; Heterocyclic Compounds, 1-Ring; Humans; Indicators and Reagents; Iodine Radioisotopes; Neoplasms; Octreotide; Radiopharmaceuticals; Receptors, Somatostatin; Yttrium Radioisotopes	1998
DOTA-lanreotide: a novel somatostatin analog for tumor diagnosis and therapy. Endocrinology, 1999, Volume: 140, Issue:11 Topics: Adenocarcinoma; Animals; Breast Neoplasms; Carcinoid Tumor; Cell Membrane; Colonic Neoplasms; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Liver Neoplasms; Lymphoma, Non-Hodgkin; Male; Neoplasms; Pancreatic Neoplasms; Peptides, Cyclic; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Thyroid Neoplasms; Tissue Distribution; Tumor Cells, Cultured; Yttrium Radioisotopes	1999
Yttrium-90 DOTATOC: first clinical results. European journal of nuclear medicine, 1999, Volume: 26, Issue:11 Topics: Adult; Aged; Female; Humans; Indium Radioisotopes; Male; Middle Aged; Neoplasms; Octreotide; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Yttrium Radioisotopes	1999
[Nuclear medicine--therapeutic advances into new dimensions?]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2000, Volume: 172, Issue:3 Topics: Animals; Glioma; Humans; Iodine Radioisotopes; Lymphoma; Neoplasms; Nuclear Medicine; Polycythemia Vera; Radiotherapy Dosage; Thyroid Neoplasms; Tumor Cells, Cultured; Yttrium Radioisotopes	2000
Dosimetry in radionuclide therapies with 90Y-conjugates: the IEO experience. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 2000, Volume: 44, Issue:4 Topics: Humans; Indium Radioisotopes; Neoplasms; Octreotide; Radioimmunotherapy; Radiopharmaceuticals; Radiotherapy Dosage; Yttrium Radioisotopes	2000
An analytic dosimetry study for the use of radionuclide-liposome conjugates in internal radiotherapy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:3 Topics: Animals; Brachytherapy; Copper Radioisotopes; Drug Carriers; Iodine Radioisotopes; Liposomes; Mice; Neoplasms; Particle Size; Radiation Dosage; Radioisotopes; Rhenium; Tissue Distribution; Yttrium Radioisotopes	2001
Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial images. Cancer biotherapy & radiopharmaceuticals, 2001, Volume: 16, Issue:5 Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Carbon Radioisotopes; Carcinoembryonic Antigen; Colorectal Neoplasms; Dose-Response Relationship, Radiation; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Immunoconjugates; Immunoglobulin G; Iodine Radioisotopes; Luminescent Measurements; Mice; Mice, Nude; Neoplasms; Radioimmunodetection; Radioimmunotherapy; Radiometry; Radiotherapy Dosage; Sensitivity and Specificity; Tissue Distribution; Transplantation, Heterologous; Yttrium Radioisotopes	2001
Production, PET performance and dosimetric considerations of 134Ce/134La, an Auger electron and positron-emitting generator for radionuclide therapy. Physics in medicine and biology, 2002, Feb-21, Volume: 47, Issue:4 Topics: Cesium Radioisotopes; Electrons; Humans; Isotopes; Kinetics; Lanthanum; Neoplasms; Radiometry; Scattering, Radiation; Tomography, Emission-Computed; Yttrium; Yttrium Radioisotopes	2002
Nephrotoxicity versus anti-tumour efficacy in radiopeptide therapy: facts and myths about the Scylla and Charybdis. European journal of nuclear medicine and molecular imaging, 2002, Volume: 29, Issue:2 Topics: Animals; Humans; Kidney; Neoplasms; Octreotide; Peptides; Radiopharmaceuticals; Radiotherapy Dosage; Yttrium Radioisotopes	2002
[Use of Y90 in experimental and clinical oncology]. Meditsinskaia radiologiia, 1976, Volume: 21, Issue:10 Topics: Biotransformation; Colloids; Hypophysectomy; Liver; Neoplasms; Radiotherapy, High-Energy; Solubility; Solutions; Stereotaxic Techniques; Yttrium Radioisotopes	1976
Choosing the right radionuclide and antibody for intraperitoneal radioimmunotherapy. Journal of the National Cancer Institute, 1991, Nov-20, Volume: 83, Issue:22 Topics: Antibodies, Monoclonal; Humans; Injections, Intraperitoneal; Neoplasms; Radiation Dosage; Radioimmunotherapy; Yttrium Radioisotopes	1991
Yttrium-90 for cancer therapy studies secured through Government and commercial suppliers. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1991, Volume: 32, Issue:2 Topics: Humans; Neoplasms; Yttrium Radioisotopes	1991
Dose distribution following selective internal radiation therapy. International journal of radiation oncology, biology, physics, 1991, Volume: 21, Issue:2 Topics: Humans; Injections, Intra-Arterial; Microspheres; Neoplasms; Radiotherapy Dosage; Yttrium Radioisotopes	1991
Macrocyclic chelates of radiometals for diagnosis and therapy. The British journal of cancer. Supplement, 1990, Volume: 10 Topics: Antibodies, Monoclonal; Chelating Agents; Cobalt Radioisotopes; Humans; Indium Radioisotopes; Metals; Neoplasms; Yttrium Radioisotopes	1990
CYT 103. Cancer investigation, 1989, Volume: 7, Issue:5 Topics: Antibodies, Monoclonal; Humans; Neoplasms; Yttrium Radioisotopes	1989
90Y-labeled monoclonal antibodies for cancer therapy. International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology, 1986, Volume: 13, Issue:4 Topics: Animals; Antibodies, Monoclonal; Cell Line; Colonic Neoplasms; Humans; Kinetics; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Radionuclide Imaging; Tissue Distribution; Transplantation, Heterologous; Yttrium Radioisotopes	1986